Afya Limited Announces MedPhone’s Acquisition
Afya Limited (Nasdaq: AFYA) announced its acquisition of 100% of MedPhone for R$6.4 million in cash.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Afya Limited (Nasdaq: AFYA) announced its acquisition of 100% of MedPhone for R$6.4 million in cash. MedPhone is a clinical decision-making app in Brazil with over 175,000 registered users and a monthly active user base of 58,000, boasting a high Net Promoter Score of 75 and an app rating of 4.9 out of 5 from over 9,100 reviews. The integration of MedPhone’s services with Afya’s PEBMED platform is expected to create synergies and enhance product offerings in the healthcare market.
Positive
- Acquisition of MedPhone for R$6.4 million expands Afya's digital healthcare offerings.
- MedPhone has a strong user base with over 175,000 registered users and high engagement (58,000 monthly active users).
- Synergies expected from integrating MedPhone with Afya's existing PEBMED platform.
Negative
- None.
Details
News Market Reaction – AFYA
The recorded move for AFYA in the trading session of this news was +5.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NOVA LIMA, Brazil, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of
MedPhone is a clinical decision and leaflet consultation app in Brazil, that helps physicians, medical students and other healthcare professionals to make faster and more accurate decisions on a daily basis. MedPhone has more than 175,000 registered users and more than 58,000 monthly active users, with a NPS of 75. The app has more than 9,100 reviews in AppStore with a 4.9 out of 5 score.
The integration of MedPhone’s clinical decision software with PEBMED will create great synergy and allow us to offer both products through the same platform.
The net purchase price was R
About Afya
Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their medical residency preparation, graduation program, and continuing medical education activities.
Contact: Investor Relations: ir@afya.com.br
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.